ATE249222T1 - Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten - Google Patents
Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthaltenInfo
- Publication number
- ATE249222T1 ATE249222T1 AT97938011T AT97938011T ATE249222T1 AT E249222 T1 ATE249222 T1 AT E249222T1 AT 97938011 T AT97938011 T AT 97938011T AT 97938011 T AT97938011 T AT 97938011T AT E249222 T1 ATE249222 T1 AT E249222T1
- Authority
- AT
- Austria
- Prior art keywords
- progestin
- estrogen
- daily dosage
- combination
- phase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69042296A | 1996-07-26 | 1996-07-26 | |
PCT/US1997/012787 WO1998004265A1 (en) | 1996-07-26 | 1997-07-23 | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE249222T1 true ATE249222T1 (de) | 2003-09-15 |
Family
ID=24772384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97938011T ATE249222T1 (de) | 1996-07-26 | 1997-07-23 | Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0921804B1 (de) |
JP (1) | JP2000515889A (de) |
KR (1) | KR20000029536A (de) |
CN (1) | CN1186023C (de) |
AT (1) | ATE249222T1 (de) |
AU (1) | AU4043597A (de) |
CA (1) | CA2261748A1 (de) |
DE (1) | DE69724796T2 (de) |
DK (1) | DK0921804T3 (de) |
ES (1) | ES2205252T3 (de) |
PT (1) | PT921804E (de) |
WO (1) | WO1998004265A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
FR2801218B1 (fr) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant |
EP1535618A1 (de) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmazeutische Zubereitung zur kontinuierlichen hormonellen Behandlung über einen Zeitraum von über 21-28 Tage beinhaltend zwei Estrogen und/oder Progestin Zusammensetzungen |
DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
ES2322479T3 (es) * | 2005-10-13 | 2009-06-22 | Bayer Schering Pharma Aktiengesellschaft | Utilizacion de valerato de estradiol en combinacion con dienogest para la terapia por via oral de la hemorragia uterina disfuncional, en union con una contracepcion oral. |
EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
WO2008049172A1 (en) * | 2006-10-27 | 2008-05-02 | Vision Biosystems Limited | A method and apparatus for dispensing substrates |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4308406C1 (de) * | 1993-03-12 | 1994-06-16 | Jenapharm Gmbh | Kombinationspräparat zur Kontrazeption |
DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
-
1997
- 1997-07-23 JP JP10508920A patent/JP2000515889A/ja not_active Ceased
- 1997-07-23 AU AU40435/97A patent/AU4043597A/en not_active Abandoned
- 1997-07-23 EP EP97938011A patent/EP0921804B1/de not_active Expired - Lifetime
- 1997-07-23 WO PCT/US1997/012787 patent/WO1998004265A1/en active IP Right Grant
- 1997-07-23 CA CA002261748A patent/CA2261748A1/en not_active Abandoned
- 1997-07-23 PT PT97938011T patent/PT921804E/pt unknown
- 1997-07-23 DK DK97938011T patent/DK0921804T3/da active
- 1997-07-23 AT AT97938011T patent/ATE249222T1/de not_active IP Right Cessation
- 1997-07-23 KR KR1019997000593A patent/KR20000029536A/ko active IP Right Grant
- 1997-07-23 ES ES97938011T patent/ES2205252T3/es not_active Expired - Lifetime
- 1997-07-23 DE DE69724796T patent/DE69724796T2/de not_active Expired - Fee Related
- 1997-07-23 CN CNB971966842A patent/CN1186023C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU4043597A (en) | 1998-02-20 |
DE69724796T2 (de) | 2004-07-01 |
JP2000515889A (ja) | 2000-11-28 |
EP0921804A1 (de) | 1999-06-16 |
DK0921804T3 (da) | 2003-11-24 |
WO1998004265A1 (en) | 1998-02-05 |
DE69724796D1 (de) | 2003-10-16 |
EP0921804B1 (de) | 2003-09-10 |
CN1226167A (zh) | 1999-08-18 |
CN1186023C (zh) | 2005-01-26 |
KR20000029536A (ko) | 2000-05-25 |
CA2261748A1 (en) | 1998-02-05 |
PT921804E (pt) | 2004-01-30 |
ES2205252T3 (es) | 2004-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE271386T1 (de) | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält | |
DK0491438T3 (da) | Svangerskabsforebyggende behandling | |
DK0491415T3 (da) | Orale svangerskabsforebyggende midler med lavt østrogen | |
DK365887D0 (da) | Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen | |
CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
WO1998004246A3 (en) | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
DK0917466T3 (da) | Oralt antikonceptionsmiddel | |
ATE249222T1 (de) | Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten | |
KR890009407A (ko) | 폐경기증세 및 골다공증의 치료를 위한 약학적 투여단위 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0921804 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |